Atherosclerotic Plaque Regression: Cause of Bypass Graft Oclussion

1. Dave T, Ezhilan J, Vasnawala H, Somani V. Plaque regression and plaque stabilisation in cardiovascular diseases. Indian J Endocrinol Metab. 2013;17(6):983-9.10.4103/2230-8210.122604Search in Google Scholar

2. Chockalingam P, Vinayagam NS, Chockalingam V, Chockalingam A. Remarkable regression of coronary atherosclerosis: An interplay of pharmacotherapeutic and lifestyle factors. Indian Heart J. 2016;68(2):188-9.10.1016/j.ihj.2015.11.012Search in Google Scholar

3. De Rosa S, Mongiardo A, Spaccarotella C, Torella D, Caiazzo G. Spontaneous Regression of Subocclusive Coronary Stenosis: Does Time Heals All Wounds. J Clin Exp Cardiolog. 2014;5(294):2.10.4172/2155-9880.1000294Search in Google Scholar

4. Shiga Y, Miura S-i, Nishikawa H, Nakamura A, Arimura T, Mitsutake R, et al. Regression of coronary plaque after coronary artery bypass graft. Journal of Cardiology Cases. 2012;5(2):e92-e5.10.1016/j.jccase.2012.01.001Search in Google Scholar

5. Jensen LO, Thayssen P, Pedersen KE, Stender S, Haghfelt T. Regression of coronary atherosclerosis by simvastatin: a serial intravascular ultrasound study. Circulation. 2004;110(3):265-70.10.1161/01.CIR.0000135215.75876.41Search in Google Scholar

6. Nissen SE. Halting the progression of atherosclerosis with intensive lipid lowering: results from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial. Am J Med. 2005;118 Suppl 12A:22-7.10.1016/j.amjmed.2005.09.020Search in Google Scholar

7. Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, et al. Effect of intensive compared with moderate lipidlowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA. 2004;291(9):1071-80.10.1001/jama.291.9.1071Search in Google Scholar

8. Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. Jama. 2006;295(13):1556-65.10.1001/jama.295.13.jpc60002Search in Google Scholar

9. Okazaki S, Yokoyama T, Miyauchi K, Shimada K, Kurata T, Sato H, et al. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study. Circulation. 2004;110(9):1061-8.10.1161/01.CIR.0000140261.58966.A4Search in Google Scholar

10. Watts GF, Lewis B, Brunt JN, Lewis ES, Coltart DJ, Smith LD, et al. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas’ Atherosclerosis Regression Study (STARS). Lancet. 1992;339(8793):563-9.10.1016/0140-6736(92)90863-XSearch in Google Scholar

11. Zhu YY, Nguyen TT, Buxton BF, Hare DL, Hayward PA. Regression of coronary disease after bypass surgery: Urban myth or common finding? J Thorac Cardiovasc Surg. 2014;148(1):53-9.10.1016/j.jtcvs.2013.07.029Search in Google Scholar

12. Paradis J-M, Fried J, Nazif T, Kirtane A, Harjai K, Khalique O, et al. Aortic stenosis and coronary artery disease: what do we know? What don’t we know? A comprehensive review of the literature with proposed treatment algorithms. European heart journal. 2014;35(31):2069-82.10.1093/eurheartj/ehu247Search in Google Scholar

13. Rapp AH, Hillis LD, Lange RA, Cigarroa JE. Prevalence of coronary artery disease in patients with aortic stenosis with and without angina pectoris. The American journal of cardiology. 2001;87(10):1216-7.10.1016/S0002-9149(01)01501-6Search in Google Scholar

14. Vandeplas A, Willems JL, Piessens J, De Geest H. Frequency of angina pectoris and coronary artery disease in severe isolated valvular aortic stenosis. Am J Cardiol. 1988;62(1):117-20.10.1016/0002-9149(88)91375-6Search in Google Scholar

15. Iung B. Interface between valve disease and ischaemic heart disease. Heart. 2000;84(3):347-52.10.1136/heart.84.3.347Open DOISearch in Google Scholar

16. El Sabbagh A, Nishimura RA. Clinical conundrum of coronary artery disease and aortic valve stenosis. Am Heart Assoc; 2017.10.1161/JAHA.117.005593Search in Google Scholar

17. Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol. 1997;29(3):630-4.10.1016/S0735-1097(96)00563-3Open DOISearch in Google Scholar

18. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, 3rd, Guyton RA, et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(23):e521-643.10.1161/CIR.000000000000003124589853Search in Google Scholar

19. Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739-91.10.1093/eurheartj/ehx39128886619Search in Google Scholar

20. Thalji NM, Suri RM, Daly RC, Greason KL, Dearani JA, Stulak JM, et al. The prognostic impact of concomitant coronary artery bypass grafting during aortic valve surgery: implications for revascularization in the transcatheter era. J Thorac Cardiovasc Surg. 2015;149(2):451-60.10.1016/j.jtcvs.2014.08.07325308117Search in Google Scholar

21. Tatoulis J, Buxton BF, Fuller JA. Patencies of 2127 arterial to coronary conduits over 15 years. Ann Thorac Surg. 2004;77(1):93-101.10.1016/S0003-4975(03)01331-6Search in Google Scholar

22. Aranki S, Aroesty J. Coronary artery bypass graft surgery: Causes and rates of graft failure 2018 [updated 2017. Available from: https://www.uptodate.com.Search in Google Scholar

23. Vos J, De Feyter P, Kingma J, Emanuelsson H, Legrand V, Winkelmann B, et al. Evolution of coronary atherosclerosis in patients with mild coronary artery disease studied by serial quantitative coronary angiography at 2 and 4 years follow-up. European heart journal. 1997;18(7):1081-9.10.1093/oxfordjournals.eurheartj.a0154019243140Search in Google Scholar

24. Nicholls SJ, Tuzcu EM, Sipahi I, Grasso AW, Schoenhagen P, Hu T, et al. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. Jama. 2007;297(5):499-508.10.1001/jama.297.5.49917284700Search in Google Scholar

25. Toth PP. High-Density Lipoprotein and Cardiovascular Risk. Circulation. 2004;109(15):1809-12.10.1161/01.CIR.0000126889.97626.B815096460Search in Google Scholar

26. Fukuda Y, Miura S-i, Tsuchiya Y, Inoue-Sumi Y, Kubota K, Takamiya Y, et al. Lower frequency of non-target lesion intervention in post-successful percutaneous coronary intervention patients with an LDL to HDL cholesterol ratio below 1.5. International journal of cardiology. 2011;149(1):120-2.10.1016/j.ijcard.2011.01.08821367470Search in Google Scholar

27. Dimitrova KR, Hoffman DM, Geller CM, Dincheva G, Ko W, Tranbaugh RF. Arterial grafts protect the native coronary vessels from atherosclerotic disease progression. Ann Thorac Surg. 2012;94(2):475-81.10.1016/j.athoracsur.2012.04.03522727250Open DOISearch in Google Scholar

28. Tu S, Xu L, Ligthart J, Xu B, Witberg K, Sun Z, et al. In vivo comparison of arterial lumen dimensions assessed by co-registered threedimensional (3D) quantitative coronary angiography, intravascular ultrasound and optical coherence tomography. Int J Cardiovasc Imaging. 2012;28(6):1315-27.10.1007/s10554-012-0016-6346378422261998Search in Google Scholar

29. Sen S, Escaned J, Malik IS, Mikhail GW, Foale RA, Mila R, et al. Development and validation of a new adenosineindependent index of stenosis severity from coronary wave-intensity analysis: results of the ADVISE (ADenosine Vasodilator Independent Stenosis Evaluation) study. J Am Coll Cardiol. 2012;59(15):1392-402.10.1016/j.jacc.2011.11.00322154731Search in Google Scholar